DocGo, Inc. (DCGO)
0.2591
0.00 (0.00%)
USD |
NASDAQ |
Oct 20, 16:00
DocGo Research and Development Expense (TTM) : 14.12M for June 30, 2026
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 14.12M |
| March 31, 2026 | 13.63M |
| December 31, 2025 | 13.56M |
| September 30, 2025 | 13.48M |
| June 30, 2025 | 13.43M |
| March 31, 2025 | 12.84M |
| December 31, 2024 | 11.59M |
| September 30, 2024 | 11.09M |
| June 30, 2024 | 11.18M |
| Date | Value |
|---|---|
| March 31, 2024 | 11.38M |
| December 31, 2023 | 10.86M |
| September 30, 2023 | 9.395M |
| June 30, 2023 | 7.533M |
| March 31, 2023 | 6.107M |
| December 31, 2022 | 5.385M |
| September 30, 2022 | 4.518M |
| June 30, 2022 | 3.810M |
| March 31, 2022 | 3.231M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Dogecoin Cash, Inc. | -- |
| Cryo-Cell International, Inc. | 0.304M |
| Privia Health Group, Inc. | -- |
| Strata Critical Medical, Inc. | 4.275M |
| Syra Health Corp. | 0.0552M |